- Home
- AQST vs EIC Comparison
AQST vs EIC Comparison
Compare AQST & EIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- EIC
- Stock Information
- Founded
- AQST 2004
- EIC N/A
- Country
- AQST United States
- EIC United States
- Employees
- AQST N/A
- EIC N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- EIC Finance/Investors Services
- Sector
- AQST Health Care
- EIC Finance
- Exchange
- AQST Nasdaq
- EIC Nasdaq
- Market Cap
- AQST 390.4M
- EIC 348.9M
- IPO Year
- AQST 2018
- EIC 2019
- Fundamental
- Price
- AQST $3.77
- EIC $13.86
- Analyst Decision
- AQST Strong Buy
- EIC Strong Buy
- Analyst Count
- AQST 6
- EIC 1
- Target Price
- AQST $10.67
- EIC $17.50
- AVG Volume (30 Days)
- AQST 1.4M
- EIC 233.8K
- Earning Date
- AQST 08-11-2025
- EIC 08-12-2025
- Dividend Yield
- AQST N/A
- EIC 11.24%
- EPS Growth
- AQST N/A
- EIC N/A
- EPS
- AQST N/A
- EIC 0.70
- Revenue
- AQST $44,132,000.00
- EIC $55,581,156.00
- Revenue This Year
- AQST N/A
- EIC $37.84
- Revenue Next Year
- AQST $38.71
- EIC $23.33
- P/E Ratio
- AQST N/A
- EIC $19.94
- Revenue Growth
- AQST N/A
- EIC 56.39
- 52 Week Low
- AQST $2.12
- EIC $12.10
- 52 Week High
- AQST $5.80
- EIC $16.71
- Technical
- Relative Strength Index (RSI)
- AQST 44.00
- EIC 70.39
- Support Level
- AQST $3.85
- EIC $12.10
- Resistance Level
- AQST $4.13
- EIC $13.15
- Average True Range (ATR)
- AQST 0.25
- EIC 0.18
- MACD
- AQST -0.03
- EIC 0.13
- Stochastic Oscillator
- AQST 13.79
- EIC 97.37
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.